Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
ID: 352945Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/352945

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-121.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)" under the T32 Clinical Trial Not Allowed mechanism. This initiative aims to develop a diverse, interdisciplinary workforce capable of conducting translational research on AD and ADRD, inviting applications from eligible higher education institutions to create training programs for predoctoral and postdoctoral researchers in various fields, including data science and behavioral research. The program is significant in addressing the growing challenges associated with AD/ADRD and aligns with the National Alzheimer's Project Act's goals of promoting team science and data-sharing collaborations. Interested institutions can apply starting April 25, 2024, with a maximum project period of five years and an anticipated funding amount of $2.7 million annually for 3-5 awards. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-121-Full-Announcement.html
    PAR-24-121.html
    The National Institutes of Health (NIH) is issuing a funding opportunity aimed at advancing institutional training programs for Alzheimer's Disease (AD) and AD-related dementias (ADRD) through the T32 Clinical Trial Not Allowed mechanism. This initiative is designed to build a diverse research workforce capable of leading interdisciplinary efforts in translational research related to AD/ADRD. The program invites applications from higher education institutions to create training that equips predoctoral and postdoctoral researchers with essential skills for conducting rigorous research across various domains, including behavioral science and data analysis. Key dates include an application opening on April 25, 2024, with a maximum project period of five years and an anticipated funding of $2.7 million annually for 3-5 awards. The proposal must emphasize the recruitment of diverse trainees and institutions, include plans for mentorship, and address the NIH's commitment to rigorous research practices. Applications are expected to follow strict guidelines, demonstrating program distinctiveness, a commitment to inclusion, and clear training objectives. This effort aligns with the goals of the National Alzheimer's Project Act which emphasizes team science and data-sharing collaborations to combat the challenges of AD/ADRD effectively.
    Similar Opportunities
    Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)." This initiative aims to develop a diverse, interdisciplinary workforce capable of conducting translational research on AD and ADRD, supporting training programs for predoctoral and postdoctoral researchers with varied educational backgrounds. The program emphasizes the importance of interdisciplinary collaboration and aims to enhance understanding and treatment of aging-related health issues. NIH plans to award an estimated 3-5 grants annually over the next three years, with a total budget of $2.7 million, and applications are due by September 25, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Institutional Translational Research Training Program (T32 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Institutional Translational Research Training Program (T32), a federal grant aimed at equipping advanced predoctoral students, postdoctoral fellows, and fellowship-stage clinicians with the skills necessary to advance basic research toward clinical application, particularly in the field of neuroscience. This program emphasizes a cohesive educational approach that integrates training in experimental design, statistical analysis, and effective communication, while fostering interdisciplinary collaboration among scientists and clinicians and providing exposure to industry and regulatory processes. The grant will cover stipends, tuition, and training-related expenses for a duration of two years, with a focus on enhancing diversity in biomedical research. Interested applicants can find more information and apply by May 25, 2026, and should direct inquiries to grantsinfo@nih.gov.
    NINDS Advanced Institutional Research Training Program (T32 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NINDS Advanced Institutional Research Training Program (T32), aimed at enhancing the training of well-qualified neuroscientists at the dissertation stage, postdoctoral fellows, and fellowship-stage clinicians. This program supports 1-2 years of mentorship and research development, focusing on diverse and rigorous training in neuroscience, including skills in scientific reasoning, experimental design, and statistical analysis, while prohibiting trainees from leading independent clinical trials. The initiative seeks to foster an inclusive research environment and bolster diverse representation within the research community, with awards covering stipends, tuition, travel, and essential training-related expenses. Applications are due by May 25 annually, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the official announcement link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-126.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for New Institutional Training Programs for Aging Research (T32, Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity for new institutional training programs focused on aging research, specifically under the T32 grant mechanism, which does not allow clinical trials. The initiative aims to establish training programs that will cultivate a diverse pool of highly trained scientists to meet the nation's biomedical, behavioral, and clinical research needs in aging. This funding is critical as it supports predoctoral and postdoctoral research training, enhancing existing programs through tailored coursework and mentored research experiences. The estimated total program funding is $1,188,000, with three awards anticipated. The Notice of Funding Opportunity (NOFO) is expected to be published in February 2025, with applications due by May 2025, and awards projected to be made by March 2026.
    Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32), aimed at enhancing training for predoctoral students in neuroscience. This program supports a two-year curriculum that emphasizes experimental design, statistical methodology, and quantitative reasoning, preparing students for careers in neuroscience research through comprehensive training and research experience. Eligible applicants include a diverse range of institutions, such as Historically Black Colleges and Universities and Hispanic-serving Institutions, with each institution allowed to submit one application based on NIH funding availability. Interested parties can find more information and application guidelines at the provided NIH link, with the application deadline set for May 25, 2025.
    Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment or renewal of Alzheimer's Disease Research Centers (ADRCs) through Grant Opportunity RFA-AG-24-001. This initiative aims to foster multidisciplinary collaboration and resource sharing among institutions dedicated to researching Alzheimer's Disease (AD) and related dementias (ADRD), with a focus on enhancing diverse perspectives in research. The program will provide a total of $32 million for seven awards in FY 2024, increasing to $65 million for 14 awards in both FY 2025 and FY 2026, with a maximum project budget of $2.925 million per year and a project period of up to five years. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov, with the application deadline set for September 26, 2025.
    Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Alzheimer's Drug-Development Program (Funding Opportunity Number: PAR-24-223), aimed at supporting the preclinical and early-stage clinical development of innovative drug candidates for Alzheimer's disease (AD). The program focuses on funding activities such as medicinal chemistry, pharmacokinetics, and Investigational New Drug (IND)-enabling studies, with the goal of advancing viable therapies to address the significant public health challenge posed by AD. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofits, and tribal organizations, with awards reaching up to $1.5 million over a period of up to five years for early-stage projects. Interested parties should submit their applications by November 5, 2027, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel Therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD)." This initiative aims to streamline the early-stage evaluation of promising pharmacological interventions by bundling independent protocols for phase 1 clinical trials with phase 1b/phase 2a trials, focusing on non-amyloid/non-tau mechanisms that address cognitive and neuropsychiatric symptoms across various stages of the disease. The program is particularly significant given the rising prevalence of Alzheimer's and the associated economic burden, emphasizing the need for innovative treatments as the aging population grows. Eligible applicants include a diverse range of organizations, such as higher education institutions and community-based organizations, with proposals due by November 19, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-226.html.
    NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIA Advanced Postdoctoral Career Transition Awards to promote diversity in translational research related to Alzheimer's disease and related dementias (AD/ADRD). This funding opportunity aims to support early-career investigators from underrepresented backgrounds, providing them with the necessary training and mentorship to develop critical research skills and transition into independent research roles. The program consists of two phases: the K99 phase for mentored training lasting up to two years, followed by the R00 phase, which offers independent research support for up to three years. Eligible applicants include various institutions and organizations, with a focus on enhancing the diversity of the research workforce. Interested parties should note that the application deadline is July 12, 2027, and can find more information at NIH Grants. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NINDS Alzheimers Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award (K99/R00 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NINDS Alzheimer's Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award (K99/R00), aimed at supporting emerging independent researchers transitioning from mentored postdoctoral positions to tenure-track faculty roles in ADRD research. This grant program seeks to cultivate a diverse pool of skilled scientists by providing up to two years of mentored support followed by a three-year independent phase, contingent on securing a faculty position, while emphasizing research that does not involve leading independent clinical trials. The initiative aligns with the National Plan to Address Alzheimer’s Disease, focusing on enhancing research capabilities to combat cognitive decline and dementia. Interested applicants must adhere to eligibility criteria, including a maximum of four years of postdoctoral experience, and can find further details and application deadlines, which span from September 2024 to December 2026, at the provided NIH link. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.